New Stock News | Rongtai Pharmaceutical Submits Application to Hong Kong Stock Exchange, Becoming the Fourth Largest Provider of Marketing and Supply Chain Solutions for China's Outpatient Pharmaceutical Market

According to the financial news app "Zhixin Finance", on September 26, as disclosed by the Hong Kong Stock Exchange, Guangdong Rongtai Pharmaceutical Co., Ltd. (referred to as Rongtai Pharmaceutical) has submitted its application for listing on the main board of the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor.